Led by Dr Ben Davis of Vernalis Research, this presentation will give a brief overview of the processes involved in identifying and developing small molecule ligands for a therapeutically relevant target, and what is then needed to turn these ligands into clinical candidates and eventually drugs. The emphasis will be on the early stages of target-based drug discovery; the various ways in which novel chemical matter can be identified and validated as interacting with the target, and some pitfalls that can be readily avoided.
*These workshops and talks are designed for researchers, academics and aspiring entrepeneurs interested in therapeutics, medical device and/or diagnostic development. We aim to support your research from concept and laboratory to clinic.
This SPARK The Midlands event is being delivered as part of Aston University's active involvement in the delivery of the West Midlands Health Tech Innovation Accelerator (WMHTIA). The WMHTIA is funded by the Department of Science, Innovation and Technology, in partnership with Innovate UK and the West Midlands Combined Authority.
For any enquiries, please email us at spark-uk@aston.ac.uk or visit www.sparkthemidlands.co.uk/contact
